In order to establish whether this might be related to an increase in PINK1 protein levels, we used samples from neurologically normal individuals (hereafter referred to as controls) and from individuals with pathologically confirmed Alzheimer disease (AD) (see Table 2 for subject characteristics). This evidence concerns the gene PINK1 and Alzheimer disease.